期刊文献+

瑞香素对2型糖尿病大鼠血清炎症因子及血糖水平的影响 被引量:1

Effect of daphnetin on levels of serum inflammatory cytokines and blood glucose in type 2 diabetic rats
原文传递
导出
摘要 目的观察瑞香素对2型糖尿病(T2DM)大鼠血清炎症因子水平的影响以及对血糖、血清胰岛素的作用,探讨瑞香素对改善糖尿病大鼠胰岛素抵抗的作用机理。方法予健康雄性Wistar大鼠高糖高脂饲料喂养30天后,腹腔注射链脲佐菌素(STZ)40mg/kg制备T2DM大鼠模型,将造模成功大鼠随机分为模型组(12例)和瑞香素组(12例),同时将正常大鼠随机分为正常组(12例)和对照组(12例)。分别予对照组和瑞香素组大鼠腹腔注射瑞香素每天4mg/kg,共注射30天,检测各组大鼠血清炎症因子、空腹血糖(FPG)和空腹胰岛素(FINS)水平,并计算胰岛素抵抗指数(HOMA-IR)。结果与正常组相比,模型组大鼠血清白细胞介素(IL)-6和肿瘤坏死因子(TNF)-α均明显升高(P〈0.01),FPG、FINS水平以及HOMA—IR也明显升高(P〈0.01)。瑞香素组大鼠的各项指标较模型组均明显降低(P〈0.05)。正常组与对照组上述指标比较差异无统计学意义(P〉0.05)。结论瑞香素可能通过降低T2DM大鼠血清炎症因子水平从而起到降低血糖和改善胰岛素抵抗的作用。 Objective To observe the effects of daphnetin on the serum levels of serum imflam- matory cytokines ,blood glucose and insulin in rats with type 2 diabetes mellitus (T2DM) and to explore the mechanism for its improvement on insulin resistance of rats. Methods T2DM rat model was induced by intravenous injection of streptozotocin(40 mg/kg) after 30 days with high glucose and high fat diet. T2DM model rats were randomized into the model group (n = 12 ) and the daphnetin group (n = 12 ). Meanwhile,normal rats were assigned to the normal group( n = 12) and the control group( n = 12). The daphnetin group and the control group were injected intraperitoneally with daphnetiu 4 mg/kg once a day for 30 days. And then serum imflammatory cytokines, fasting plasma glucose (FPG), fasting insulin (FINS) and insulin resistance index ( HOMA-IR ) of all the rats were measured. Results Compared with the normal group, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) of the model group were significantly bigher(P 〈 0.01 ) as well as FPG, FINS and HOMA-IR (P 〈 0.01 ). Compared with the model group, above indexes were significantly lower in the daphnetin group ( P 〈 0.05 ). No significant differences of above indexes between the normal group and the control group were found ( P 〉 0.05 ). Conclusion Daphnetin can lower blood glucose and reduce insulin resistance by decreasing the level of inflammatory cytokines in T2DM rats.
出处 《临床内科杂志》 CAS 2017年第11期775-777,共3页 Journal of Clinical Internal Medicine
关键词 2型糖尿病 血糖 胰岛素抵抗 炎症因子 瑞香素 Type 2 diabetes mellitus Blood glucose Insulin resistance Inflammatory cytokines Daphnetin
  • 相关文献

参考文献3

二级参考文献32

  • 1祝玮,尹爱莉,于珮.糖尿病肾病患者的血液流变学分析[J].实用糖尿病杂志,2005,1(3):18-19. 被引量:6
  • 2曲淑岩 姜秀莲 等.瑞香素抗血栓作用[J].药学学报,1986,21(7):498-498.
  • 3XUSY,BIANRL,CHENX.Methodology of Pharmacological Experiments[M].2nd ed Beijing:People′s Medical Publishing House,2002:1276-1304.
  • 4Hammond KJ,Kronenberg M.Natural killer T cells:natural or unnatural regulators of autoimmunity? Curr.Opin.Immunol.2003,15:683-689.
  • 5Camara NO,Ng WF,Hernandes-Fuentes M,et al.Human CD+4CD+25T cells regulate CD+8 T-cell activation.Transplant Proc,2002,34:2858-2860.
  • 6Feili-Hariri M,Falkner DH,Morel PA.Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.Eur J Immunol,2002,32:2021-2030.
  • 7Alard P,Manirarora JN,Parnell SA,et al.Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD+4CD+25 T-cell-mediated regulation and type 1 diabetes development in NOD mice.Diabetes,2006,55:2098-2105.
  • 8Bouwman LH,Eerligh P,Terpstra OT,et al.Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles.Diabetes,2005,54:3002-3006.
  • 9Medzhitov R,Janeway C.Innate immunity.N Engl J Med,2000,343:338-344.
  • 10Huth C,Heid IM,Vollmert C,et al.IL6 gene promoter polymorphisms and type 2 diabetes:joint analysis of individual participants'data from 21 studies.Diabetes,2006,55:2915-2921.

共引文献19

同被引文献10

引证文献1

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部